Transfusion-transmitted tick-borne infections: A cornucopia of threats

Transfusion Medicine Reviews

Volumn 18, Issue 4, 2004, Pages 293-306

  Leiby, David A ^a,b   Gill, Jennifer E ^a  

^a HOLLAND LABORATORY   (United States)

^b AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' AMINOMETHYL 4,5',8 TRIMETHYLPSORALEN; AMIDE; ANTIBIOTIC AGENT; ATOVAQUONE; AZITHROMYCIN; CHLORAMPHENICOL; CLINDAMYCIN; DOXYCYCLINE; IMMUNOGLOBULIN ANTIBODY; N (4 BUTANOL)PHEOPHORBAMIDE; PSORALEN DERIVATIVE; QUININE; TETRACYCLINE; UNCLASSIFIED DRUG;

AMBLYOMMA; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANTIBIOTIC THERAPY; ASPLENIA; BABESIA; BABESIOSIS; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL FEATURE; COLORADO TICK FEVER; COLORADO TICK FEVER VIRUS; COMPLEMENT FIXATION; DERMACENTOR; DISEASE CARRIER; EHRLICHIA; EHRLICHIOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; FEVER; HEMOLYTIC ANEMIA; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOFLUORESCENCE TEST; IXODES; KIDNEY FAILURE; LYME DISEASE; NEORICKETTSIA SENNETSU; NEUROLOGICAL COMPLICATION; NONHUMAN; NUCLEIC ACID ANALYSIS; PARASITEMIA; PARESIS; POLYMERASE CHAIN REACTION; REVIEW; RHEUMATOID ARTHRITIS; RICKETTSIA RICKETTSII; RICKETTSIOSIS; ROCKY MOUNTAIN SPOTTED FEVER; SCREENING TEST; SCRUB TYPHUS; SEROLOGY; SEROPREVALENCE; SIDE EFFECT; SKIN BIOPSY; SPIROCHETE; SURVIVAL; THREAT; THROMBOCYTOPENIA; TICK; TICK BITE; TICK BORNE DISEASE; TICK BORNE ENCEPHALITIS FLAVIVIRUS; WESTERN BLOTTING;

EID: 6344290034     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.07.001     Document Type: Article

References (111)

1. Spach D.H., Liles W.C., Campbell G.L., et al. Tick-borne diseases in the United States. New Engl J Med. 329:1993;936-947
2. Walker D.H. Tick-transmitted infectious diseases in the United States. Annu Rev Public Health. 19:1998;237-269
3. Burgdorfer W., Barbour A.G., Hayes S.F., et al. Lyme disease - A tick-borne spirochetosis? Science. 216:1982;1317-1319
4. Benach J.L., Bosler E.M., Hanrahan J.P., et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med. 308:1983;740-742
5. Steere A.C., Grodzicki R.L., Kornblatt A.N., et al. The spirochetal etiology of Lyme disease. N Engl J Med. 308:1983;733-740
6. Fishbein D.B., Sawyer L.A., Holland C.J., et al. Unexplained febrile illnesses after exposure to ticks Infection with an Ehrlichia? JAMA. 257:1987;3100-3104
7. Maeda K., Markowitz N., Hawley R.C., et al. Human infection with Ehrlichia canis, a leukocytic rickettsia. N Eng J Med. 316:1987;853-856
8. Anderson B.E., Dawson J.E., Jones D.C., et al. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Micobiol. 29:1991;2838-2842
9. Bakken J.S., Dumler J.S., Chen S.-M., et al. Human granulocytic ehrlichiosis in the Upper Midwest United States A new species emerging? JAMA. 272:1994;212-218
10. Chen S.-M., Dumler S.J., Bakken J.S., et al. Identification of a granulocytic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol. 32:1994;589-595
11. Quick R.E., Herwaldt B.L., Thromford J.W., et al. Babesiosis in Washington State A new species of Babesia? Ann Intern Med. 119:1993;284-290
12. Herwaldt B.L., Persing D.H., Précigout E.A., et al. A fatal case of babesiosis in Missouri Identification of another piroplasm that infects humans. Ann Intern Med. 124:1996;643-650
13. Arguin P.M., Singleton J., Rotz L.D., et al. An investigation into the possibility of transmission of tick-borne pathogens via blood transfusion. Transfusion. 39:1999;828-833
14. McQuiston J.H., Childs J.E., Chamberland M.E., et al. Transmission of tick-borne agents by blood transfusion A review of known and potential risks in the United States. Transfusion. 40:2000;274-284
15. Pantanowitz L., Telford S.R., Cannon M.E. The impact of babesiosis on transfusion medicine. Transfusion Med Rev. 16:2002;131-143
16. Pantanowitz L., Telford S.R., Cannon M.E. Tick-borne diseases in transfusion medicine. Transfusion Med. 12:2002;85-106
17. Goethert H.K., Telford S.R. Enzootic transmission of Babesia divergens among cottontail rabbits on Nantucket Island, Massachusetts. Am J Trop Med Hyg. 69:2003;455-460
18. Kjemtrup A.M., Conrad P.A. Human babesiosis An emerging tick-borne disease. Int J Parasitol. 30:2000;1323-1337
19. White D.J., Talarico J., Chang H.-G., et al. Human babesiosis in New York State Review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med. 158:1998;2149-2154
20. Persing D.H., Herwaldt B.L., Glaser C., et al. Infection with a Babesia-like organism in northern California. N Engl J Med. 332:1995;298-303
21. Beattie J.F., Michelson M.L., Holman P.J. Acute babesiosis caused by Babesia divergens in a resident of Kentucky. N Engl J Med. 347:2002;697-698
22. Homer M.J., Aguilar-Delfin I., Telfored S.R., et al. Babesiosis. Clin Microbiol Rev. 13:2000;451-469
23. Gorenflot A., Moubri K., Precigout E., et al. Human babesiosis. Ann Trop Med Parasitol. 92:1998;489-501
24. Herwaldt B.L., Cacciò S., Gherlinzoni F., et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Inf Dis. 9:2003;942-948
25. Saito-Ito A., Tsuji M., Wei Q., et al. Transfusion-acquired, autochthonous human babesiosis in Japan Isolation of Babesia microti-like parasites with hu-RBC-SCID mice. J Clin Microbiol. 38:2000;4511-4516
26. Misao T., Koboyashi Y. Studies on infectious mononucleosis isolation of etiologic agent from blood, bone marrow, and lymph node of a patient with infectious mononucleosis by using mice. Tokyo Iji Shinshi. 71:1954;683-686
27. Perez M., Rikihisa Y., Wen B. Ehrlichia canis-like agent isolated from a man in Venezuela Antigenic and genetic characterization. J Clin Microbiol. 34:1996;2133-2139
28. Buller R.S., Arens M., Hmiel S.P., et al. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N Engl J Med. 341:1999;148-155
29. Dumler J.S., Barbet A.F., Bekker C.P.J., et al. Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales Unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and "HGE agent" as subjective synonyms of Ehrlichia phagocytophila. Int J Syst Evol Microbiol. 51:2001;2145-2165
30. Bakken J.S., Dumler J.S. Human granulocytic ehrlichiosis. Clin Infect Dis. 31:2000;554-560
31. Heo E.-j., Park J.-h., Koo J.-r., et al. Serologic and molecular detection of Ehrlichia chaffeensis and Anaplasma phagocytophila (human granulocytic ehrlichiosis agent) in Korean patients. J Clin Microbiol. 40:2002;3082-3085
32. Dumler J.S., Bakken J.S. Ehrlichial diseases of humans Emerging tick-borne infections. Clin Infect Dis. 20:1995;1102-1110
33. Keysary A., Amram L., Keren G., et al. Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Inf Dis. 5:1999;775-778
34. Brouqui P., Dumler J.S. Letter to the Editor Serologic evidence of human monocytic and granulocytic ehrlichiosis in Israel. Emerg Inf Dis. 6:2000;314
35. Walker D.H. Rickettsioses of the spotted fever group around the world. J Dermatol. 16:1989;169-177
36. Dalton M.J., Clarke M.J., Holman R.C., et al. National surveillance for Rocky Mountain spotted fever, 1981-1992 Epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg. 52:1995;405-413
37. Treadwell T.A., Holman R.C., Clarke M.J., et al. Rocky Mountain spotted fever in the United States, 1993-1996. Am J Trop Med Hyg. 63:2000;21-26
38. de Lemos E.R.S., Alvarenga F.B.F., Cintra M.L., et al. Spotted fever in Brazil A seroepidemiological study and description of clinical cases in an endemic area in the state of São Paulo. Am J Trop Med Hyg. 65:2001;329-334
39. Emmons R.W. Ecology of Colorado tick fever. Ann Rev Microbiol. 42:1988;49-64
40. Ecker M., Allison S.L., Meixne T., et al. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol. 80:1999;179-185
41. Dumpis U., Crook D., Oksi J. Tick-borne encephalitis. Clin Infect Dis. 28:1999;882-890
42. Outbreak of Powassan Encephalitis - Maine and Vermont, 1999-2001. MMWR. 50:2001;761-764
43. Meldrum S.C., Birkhead G.S., White D.J., et al. Human babesiosis in New York State An epidemiologic description of 136 cases. Clin Infect Dis. 15:1992;1019-1023
44. Fritz C.L., Glaser C.A. Ehrlichiosis. Infect Dis Clin North Am. 341:1998;148-155
45. Hughes L.E., Casper E.A., Clifford C.M. Persistence of Colorado tick fever virus in red blood cells. Amer J Trop Med Hyg. 23:1974;530-532
46. Greşíková M., Kaluzová M. Biology of tick-borne encephalitis virus. Acta Virologica. 41:1997;115-124
47. Strle F., Nadelman R.B., Cimperman J., et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 130:1999;32-36
48. Fishbein D.B., Dawson J.E., Robinson L.A. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med. 120:1994;736-743
49. Chisholm E.S., Ruebush T.K., Sulzer A.J., et al. Babesia microti infection in man Evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg. 27:1978;14-19
50. Persing D.H., Mathiesen D., Marshall W.F., et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. 30:1992;2097-2103
51. Olmeda A.S., Armstrong P.M., Rosenthal B.M., et al. A subtropical case of human babesiosis. Acta Trop. 67:1997;229-234
52. Herwaldt B.L., Kjemtrup A.M., Conrad P.A., et al. Transfusion-transmitted babesiosis in Washington state First reported case caused by a WA1-type parasite. J Infect Dis. 175:1997;1259-1262
53. Everett E.D., Evans K.A., Henry R.B., et al. Human ehrlichiosis in adults after tick exposure Diagnosis using polymerase chain reaction. Ann Intern Med. 120:1994;730-735
54. Massung R.F., Slater K., Owens J.H., et al. Nested PCR assay for detection of granulocytic ehrlichiae. J Clin Microbiol. 36:1998;1090-1095
55. Walls J.J., Aguero-Rosenfeld M., Bakken J.S., et al. Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by immunofluorescent-antibody test. J Clin Microbiol. 37:1999;2968-2973
56. Dumler J.S., Walker D.H. Diagnostic tests for Rocky Mountain spotted fever and other rickettsial diseases. Dermatol Clin. 12:1994;25-36
57. Emmons R.W., Lenette E.H. Immunofluorescent staining in the laboratory diagnosis of Colorado tick fever. J Lab Clin Med. 68:1996;923-929
58. Attoui H., Billoir F., Bruey J.-N., et al. Serologic and molecular diagnosis of Colorado tick fever viral infections. Am J Trop Med Hyg. 59:1998;763-768
59. Calisher C.H., Poland J.D., Calisher S.B., et al. Diagnosis of Colorado tick fever virus infection by enzyme immunoassays for immunoglobulin M and G antibodies. J Clin Microbiol. 22:1985;84-88
60. Johnson A.J., Karabatsos N., Lanciotti R.S. Detection of Colorado tick fever virus by using reverse transcriptase PCR and application of the technique in laboratory diagnosis. J Clin Microbiol. 35:1997;1203-1208
61. Holzmann H., Kundi M., Stiasny K., et al. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol. 48:1996;102-107
62. Whitby J.E., Ni H.E., Whitby A.D., et al. Rapid detection of viruses of the tick-borne encephalitis complex by RT-PCR of viral RNA. J Virol Methods. 45:1993;115-119
63. Krause P.J., Lepore T., Sikand V.K., et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 343:2000;1454-1458
64. Machtinger L., Telford S.R., Inducil C., et al. Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient. J Clin Apheresis. 8:1993;78-81
65. Dorman S.E., Cannon M.E., Telford S.R., et al. Fulminant babesiosis treated with clindamycin, quinine, and whole-blood exchange transfusion. Transfusion. 40:2000;375-380
66. Telford S.R., Foppa I.M. Tickborne encephalitides. Cunha B.A. Tickborne Infectious Diseases Diagnosis and Management. 2000;193-213 Marcel Dekker, Inc, New York, NY
67. Magnarelli L.A., Ijdo J.W., Anderson J.F., et al. Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. J Clin Microbiol. 36:1998;2823-2827
68. Mitchell P.D., Reed K.D., Hofkes J.M. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J Clin Microbiol. 34:1996;724-727
69. Krause P.J., Telford S.R., Spielman A., et al. Concurrent Lyme disease and babesiosis. JAMA. 275:1996;1657-1660
70. Wang T.J., Liang M.H., Sangha O., et al. Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of Lyme disease. Clin Infect Dis. 31:2000;1149-1154
71. Leiby D.A., Chung A.P.S., Cable R.G., et al. Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors. Transfusion. 42:2002;1585-1591
72. Krause P.J., Telford S.R., Ryan R., et al. Geographical and temporal distribution of babesial infection in Connecticut. J Clin Microbiol. 29:1991;1-4
73. Linden J.V., Wong S.J., Chu F.K., et al. Transfusion-associated transmission of babesiosis in New York State. Transfusion. 40:2000;285-289
74. Fritz C.L., Kjemtrup A.M., Conrad P.A., et al. Seroepidemiology of emerging tickborne infectious diseases in a Northern California community. J Infect Dis. 175:1997;1432-1439
75. Uhnoo I., Cars O., Christensson D., et al. First documented case of human babesiosis in Sweden. Scand J Infect Dis. 24:1992;541-547
76. Hunfeld K.P., Allwinn R., Peters S., et al. Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from Midwestern Germany. Wien Klin Wochenschr. 119:1998;901-908
77. Hunfeld K.P., Lambert A., Kampen H., et al. Seroprevalence of Babesia infections in humans exposed to ticks in Midwestern Germany. J Clin Microbiol. 40:2002;2431-2436
78. Hilton E., DeVoti J., Benach J.L., et al. Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med. 106:1999;404-409
79. Bakken J.S., Goellner P., Van Etten M., et al. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin Infect Dis. 27:1998;1491-1496
80. Aguero-Rosenfeld M.E., Donnarumma L., Zentmaier L., et al. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol. 40:2002;2612-2615
81. Pratt K.M., Gill J.E., Leiby D.A., et al. Evidence of Anaplasma phagocytophilum, the agent of human granulocytic ehrlichiosis, in blood donors from tick-borne disease endemic areas of Connecticut. Transfusion. 43:(Suppl):2003;45A. (suppl, abstr)
82. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 2001. MMWR. 50:2001;2-3
83. Leiby D.A. Babesia and other parasites. Brecher M.E. Bacterial and Parasitic Contamination of Blood Components. 2003;179-200 AABB Press, Bethesda, MD
84. Matsui T., Inoue R., Kajimoto K., et al. First documentation of transfusion-associated babesiosis in Japan. Rinsho Ketsueki. 41:2000;628-634. [article in Japanese with English summary]
85. Jassoum B.S., Fong I.W., Hannach B., et al. Transfusion-transmitted babesiosis in Ontario first reported case in Canada. Can Commun Dis Rep. 26:2000;9-13
86. Kjemtrup A.M., Lee B., Fritz C.L., et al. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion. 42:2002;1482-1487
87. Gerber M.A., Shapiro E.D., Krause P.J., et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Inf Dis. 170:1994;231-234
88. Cable R.G., Badon S., Trouern-Trend, et al. Evidence for transmission of Babesia microti from Connecticut blood donors to recipients. Transfusion. 41:(suppl):2001;12S-13S. abstr
89. Eastlund T., Persing D., Mathiesen D., et al. Human granulocytic ehrlichiosis after red cell transfusion. Transfusion. 39:(suppl):1999;117S. (abstr)
90. Wells G.M., Woodward T.E., Fiset P., et al. Rocky Mountain spotted fever caused by blood transfusion. JAMA. 239:1978;2763-2765
91. Randall W.H., Simmons J., Casper E.A., et al. Transmission of Colorado tick fever virus by blood transfusion - Montana. MMWR. 24:1975;422-427
92. Wahlberg P., Saikku P., Brummer-Korvenkontio M., et al. Tick-borne viral encephalitis in Finland The clinical features of Kumlinge disease during 1959-1987. J Intern Med. 225:1989;173-177
93. Eberhard M.L., Walker E.M., Steurer F.J. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol. 81:1995;790-792
94. Mintz E.D., Anderson J.F., Cable R.G., et al. Transfusion-transmitted babesiosis A case report from a new endemic area. Transfusion. 31:1991;365-368
95. Kalantarpour F., Chowdhury I., Wormser G.P., et al. Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions. J Clin Microbiol. 38:2000;2398-2399
96. Philip R.N., Casper E.A., Cory J., et al. The potential for transmission of arboviruses by blood transfusion with particular reference to Colorado tick fever. Greenwalt T.J., Jamison G.A. Transmissible Disease & Blood Transfusion. 1975;175-195 Grune & Stratton, New York, NY
97. Mather T.N., Telford S.R., Moore S.I., et al. Borrelia burgdorferi and Babesia microti Efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp Parasitol. 70:1990;55-61
98. Piesman J., Spielman A. Babesia microti Infectivity of parasites from ticks from hamsters and white-footed mice. Exp Parasitol. 53:1982;242-248
99. Piesman J., Mather T.N., Sinsky R.J., et al. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol. 25:1987;557-558
100. des Vignes F., Piesman J., Heffernan R., et al. Effect of tick removal on transmission of Borrelia burgdorferi and Anaplasma phagocytophila by Ixodes scapularis nymphs. J Inf Dis. 183:2001;773-778
101. Krause P.J., Spielman A., Telford S.R., et al. Persistent parasitemia after acute babesiosis. N Engl J Med. 339:1998;160-164
102. Johnson S.T., Cable R.G., Trouern-Trend J., et al. Frequency and duration of Babesia microti parasitemia in seropositive blood donors. Transfusion. 43:(suppl):2003;13A. (abstr)
103. Houghton R.L., Homer M.J., Reynolds L.D., et al. Identification of Babesia microti-specific immunodominant epitopes and development of a peptide EIA for detection of antibodies in serum. Transfusion. 42:2002;1488-1496
104. Homer M.J., Lodes M.J., Reynolds L.D., et al. Identification and characterization of putative secreted antigens from Babesia microti. J Clin Microbiol. 41:2003;723-729
105. Gibble J., Leiby D., Jacob M., et al. Transfusion-transmission of babesiosis from asymptomatic blood donor to an elderly woman in Baltimore, Maryland. Transfusion. 39:(suppl):1999;5S
106. Mettille F.C., Salata K.F., Belanger K.J., et al. Reducing the risk of transfusion-transmitted rickettsial disease by WBC filtration, using Orientia tsutsugamushi in a model system. Transfusion. 40:2000;290-296
107. McKechnie D.B., Slater K.S., Childs J.E., et al. Survival of Ehrlichia chaffeensis in refrigerated, ADSOL-treated RBCs. Transfusion. 40:2000;1041-1047
108. Belanger K.J., Kelly D.J., Mettille F.C., et al. Psoralen photochemical inactivation of Orientia tsutsugamushi in platelet concentrates. Transfusion. 40:2000;1503-1507
109. Grellier P., Santus R., Louray E., et al. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang. 72:1997;211-220
110. Chang C.C., Chomel B.B., Kasten R.W., et al. Molecular evidence of Bartonella spp. in questing adult Ixodes pacificus ticks in California. J Clin Microbiol. 39:2001;1221-1226
111. Sanogo Y.O., Zeaiter Z., Caruso G., et al. Bartonella henselae in Ixodes ricinus ticks (Acari: Ixodida) removed from humans, Belluno Province, Italy. Emerg Inf Dis. 9:2003;329-332